Amdani Shahnawaz, Altman Carolyn A, Chowdhury Devyani, Ronai Christina, Soma David, Archer Jeremy M, Tierney Seda, Renno Marukus S, Miller Jacob, Nguyen Quang-Tuyen, Glickstein Julie S, Orr William B
Division of Cardiology & Cardiovascular Medicine, Children's Institute Department of Heart Vascular & Thoracic, Cleveland, OH, USA.
Lillie Frank Abercrombie Section of Pediatric Cardiology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
Curr Pediatr Rev. 2024 Oct 2. doi: 10.2174/0115733963314978240923110844.
The novel Coronavirus Disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, created a need for evidence-based guidelines for the evaluation, management, and follow-up after infection. Data have become rapidly available, creating a challenge for medical providers to stay abreast of the ever-evolving recommendations. This document, written collaboratively by pediatric cardiovascular experts, pediatricians, and sports medicine specialists, is focused on SARS-- CoV-2-related pediatric cardiac manifestations. It aims to provide a systemic review of high-yield literature related to all cardiovascular entities as a tool for primary pediatric clinicians to utilize as they consider the cardiac consequences of acute SARS-CoV-2 infection, MIS-C, vaccine-related myocarditis, return-to-play, and long COVID-19 syndrome.
由严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)引起的2019年新型冠状病毒病(COVID-19),使得有必要制定基于证据的指南,用于感染后的评估、管理和随访。数据迅速可得,这给医疗服务提供者带来了挑战,要跟上不断变化的建议。本文档由儿科心血管专家、儿科医生和运动医学专家共同撰写,重点关注与SARS-CoV-2相关的儿科心脏表现。它旨在对与所有心血管实体相关的高产文献进行系统综述,作为初级儿科临床医生在考虑急性SARS-CoV-2感染、儿童多系统炎症综合征(MIS-C)、疫苗相关心肌炎、恢复运动和长期COVID-19综合征的心脏后果时使用的工具。